In vitro measurement of chemosensitivity of human small cell lung and gastric cancer cell lines toward cell cycle phase‐nonspecific agents under the clinically equivalent area under the curve

Cancer

Volumn 70, Issue 10, 1992, Pages 2540-2546

  Mitsuhashi, Yoshihiro ^a   Lnaba, Makoto ^b   Sugiyama, Yuichi ^c   Kohayashi, Tomowo ^a  

^a DAIICHI SANKYO CO   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

cell cycle phase nonspecific agent; clinical AUC; gastric cancer; in vitro AUC; in vitro chemosensitivity; mitomycin C; MTT assay; nimustine hydrochloride; small cell lung carcinoma

Indexed keywords

MITOMYCIN C; NIMUSTINE; TETRAZOLIUM;

AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE; CELL KILLING; COLORIMETRY; CONTROLLED STUDY; DRUG DECOMPOSITION; DRUG EFFICACY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; STOMACH CANCER;

CARCINOMA, SMALL CELL; CELL CYCLE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMAN; LUNG NEOPLASMS; MITOMYCINS; NIMUSTINE; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0026443747     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19921115)70:10<2540::AID-CNCR2820701024>3.0.CO;2-2     Document Type: Article

References (29)

1. Cell killing action of cell cycle phase‐non‐specific antitumor agents is dependent on concentration‐time product
2. Tabular analysis of the clinical chemotherapy of solid tumors
3. Present status of lung cancer chemotherapy in Japan
4. Experimental and clinical effect of ACNU in Japan, with emphasis on small‐cell carcinoma of the lung
5. Clinical studies of new nitrosoureas under development in Japan
6. Interconversion of biological characteristics of small cell lung cancer depending on culture conditions
7. Establishment of continuous, clonable cultures of small‐cell carcinoma of the lung which have amine precursor uptake and decarboxylation cell properties
8. Establishment of human continuous cell lines from squamous cells, adeno‐ and small cell carcinoma of the lung and the results of heterotransplantation
9. Comparison of antitumor activity of platinum analogues in lung cancer using human tumor clonogenic assay (HTCA) [abstract]
10. In vitro properties of epithelial cell lines established from human carcinomas and nonmalignant tissue
11. Establishment of cultured cell lines derived from a human gastric carcinoma
12. Evaluation of the regrowth assay method as an in vitro drug sensitivity test and its application to cultured human gastric cancer cell lines
13. Characteristics of three human gastric cancer cell lines, NU‐GC‐2, NU‐GC‐3, and NU‐GC‐4
14. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay
15. Evaluation of a tetrazolium‐based semiautomated colorimetric assay: assessment of chemosensitivity testing
16. Prediction of ACNU plasma concentration: time profiles in humans by animal scale‐up
17. Disposition of anticancer drugs after bolus arterial administration in a tissue‐isolated tumor perfusion system
18. Quantitative determination of ACNU, 1‐[(4‐amino‐2‐methyl‐5‐pyrimidinyl)‐methyl]‐3‐(2‐chloroethyl)‐3‐nitrosourea hydrochloride, a new water soluble antitumor nitrosourea, in biological fluids and tissues of patients by high‐performance liquid chromatography: I. analytical method and pharmacokinetics
19. Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combination
20. Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay
21. Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium‐based colorimetric assay
22. Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and Chinese hamster cells
23. Chemosensitivity patterns and expression of human multidrug resistance‐associated MDR 1 gene by human gastric and colorectal carcinoma cell liners
24. Acquisition of resistance to 1‐(4‐amino‐2‐methyl‐5‐pyrimidinyl)methyl‐3‐(2‐chloroethyl)‐3‐nitrosourea hydrochloride in V79 cells through increased removal of O6‐alkylguanine
25. O6‐methylguanine methyltransferase activity and sensitivity of Japanese tumor cell strains to 1‐(4‐amino‐2‐methyl‐5‐pyrimidinyl)methyl‐3‐(2‐chloroethyl)‐3‐nitrosourea hydrochloride
26. Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions
27. Decreased NADPH: cytochrome P‐450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions
28. Dosage regimen design for pharmaceutical studies conducted in animals
29. Pharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI‐921, a new analogue, in mice, rats, rabbits, dogs, and humans